MG

Martin E. Gleave

UC University Of British Columbia: 51 patents #1 of 1,308Top 1%
CD Centre For Drug Research And Development: 4 patents #1 of 16Top 7%
TI Teva Pharmaceutical Industries: 2 patents #183 of 489Top 40%
📍 Vancouver, CA: #25 of 5,070 inventorsTop 1%
Overall (All Time): #47,092 of 4,157,543Top 2%
54
Patents All Time

Issued Patents All Time

Showing 26–50 of 54 patents

Patent #TitleCo-InventorsDate
8710020 Clusterin antisense therapy for treatment of cancer Scott D. Cormack 2014-04-29
8580761 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same Maxim Signaevsky 2013-11-12
8541390 Treatment of cancer by inhibition of IGFBPs and clusterin 2013-09-24
8536149 TRPM-2 antisense therapy Paul S. Rennie, Hideaki Miyake, Colleen Nelson 2013-09-17
8470796 Treatment of cancer by inhibition of IGFBPs and clusterin 2013-06-25
8389491 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same Maxim Signaevsky 2013-03-05
8361981 Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides Paul S. Rennie, Hideaki Miyake, Colleen Nelson, Tobias Zellweger 2013-01-29
8252765 Treatment of cancer by inhibition of IGFBPs and clusterin 2012-08-28
8252918 RNAi probes targeting cancer-related proteins Burkhard Jansen, Ioannis P. Trougakos, Efstathios Gonos, Maxim Signaevsky, Eliana Beraldi 2012-08-28
8173615 TRPM-2 antisense therapy Paul S. Rennie, Hideaki Miyake, Colleen Nelson 2012-05-08
8168610 Bispecific oligonucleotide for the treatment of CNS malignancies Michael N. Pollak, Randy J. Leavitt 2012-05-01
7973017 Treatment of cancer by inhibition of IGFBP's and clusterin 2011-07-05
7964717 RNAi probes targeting cancer-related proteins Burkhard Jansen, Ioannis P. Trougakos, Efstathios Gonos, Maxim Signaevsky, Eliana Beraldi 2011-06-21
7932234 Bispecific oligonucleotide for the treatment of CNS malignancies Michael N. Pollak, Randy J. Levitt 2011-04-26
7928082 Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same Maxim Signaevsky 2011-04-19
7847091 Compositions and methods for treatment of prostate and other cancers Palma Rocchi, Maxim Signaevsky, Eliana Beraldi 2010-12-07
7820635 RNAi probes targeting cancer-related proteins Burkhard Jansen, Ioannis P. Trougakos, Efstathios Gonos, Maxim Signaevsky, Eliana Beraldi 2010-10-26
7732422 TRPM-2 antisense therapy Paul S. Rennie, Hideaki Miyake, Colleen Nelson 2010-06-08
7723312 Compositions and methods for treatment of prostate and other cancers Palma Rocchi, Maxim Signaevsky, Eliana Beraldi 2010-05-25
7592323 TRPM-2 antisense therapy Paul S. Rennie, Hideaki Miyake, Colleen Nelson 2009-09-22
7569551 Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides Paul S. Rennie, Hikeaki Miyake, Colleen Nelson, Tobias Zellweger 2009-08-04
7550580 Compositions and methods for treatment of prostate and other cancers Palma Rocchi, Maxim Signaevsky, Eliana Beraldi 2009-06-23
7534773 TRPM-2 antisense therapy Paul S. Rennie, Hideaki Miyake, Colleen Nelson 2009-05-19
7368436 TRPM-2 antisense therapy Paul S. Rennie, Hideaki Miyake, Colleen Nelson 2008-05-06
7297684 Antisense therapy for hormone-regulated tumors Hideaki Miyake 2007-11-20